Product Information

CLOMIPRAMINE 75 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3035 per EA under NDC 16571068509. Its NADAC has been published 301 times since Feb 17, 2021.

FDA first approved this application on Aug 7, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLOMIPRAMINE 75 MG CAPSULE

Clomipramine Hydrochloride
$0.3035per EA

Strength

75 mg/1

NDC

16571068509

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CLOMIPRAMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212285

FDA Approved

8/7/2020

TE Code

AB

On Market Since

11/1/2020

Pharmacological Classes

Price Statistics

The NADAC for CLOMIPRAMINE 75 MG CAPSULE has been published 301 times since Feb 17, 2021, and over the history we have for it it has declined 85.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3035 per EA
All-time high$2.1004 (Sep 15, 2021)
All-time low$0.2501 (Sep 23, 2026)
52-week high$0.3604
52-week low$0.2501
Median price$0.5042
Average price$0.6528
Largest weekly change+73.5% (Jun 19, 2024)
Weeks tracked301
Tracking sinceFeb 17, 2021

Price History

1W

+12.4%

1M

+21.3%

3M

+15.1%

6M

+2.7%

1Y

-21.3%

3Y

-52.7%

5Y

-76.0%

All

-85.3%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLOMIPRAMINE 75 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 75 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.3035 per EA (NDC 16571068509), effective Nov 18, 2026.

How has the price of CLOMIPRAMINE 75 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CLOMIPRAMINE 75 MG CAPSULE has declined 85.3%. It has been tracked across 301 weekly CMS publications since Feb 17, 2021.

What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 75 MG CAPSULE?

Since Feb 17, 2021, the NADAC for CLOMIPRAMINE 75 MG CAPSULE has ranged from a low of $0.2501 (Sep 23, 2026) to a high of $2.1004 (Sep 15, 2021), with a median of $0.5042 per EA.

Are there cheaper alternatives to CLOMIPRAMINE 75 MG CAPSULE?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOMIPRAMINE 75 MG CAPSULE, is $0.2907 per EA — about 4% below CLOMIPRAMINE 75 MG CAPSULE.

Who manufactures CLOMIPRAMINE 75 MG CAPSULE?

CLOMIPRAMINE 75 MG CAPSULE (NDC 16571068509) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.